Researchers have developed eye drops that extend vision in animal models of a group of inherited diseases that lead to progressive vision loss in humans, known as retinitis pigmentosa.

GeekWire Award finalists for Health Innovation of the Year are dominated by ventures that aim to outwit cancer with ...

The H5N1 avian influenza virus is mutating to evade immune defenses in mammals following prior infection or vaccination.

CEPI is providing US$4.5 million to non-profit Fondazione Biotecnopolo di Siena (FBS) for proof-of-concept research that will ...

The pursuit of a cure for Alzheimer's disease is becoming an increasingly competitive and contentious quest with recent years ...

A screen of human-infecting viruses identified extensive examples of viral proteins that resembled human sequences, which ...

Researchers at UZH have developed a technology that can be used to test around 25 antibodies simultaneously in a single mouse ...

Many modern drugs are based on antibodies. These proteins very specifically identify a certain structure on the surface of ...

Galux Inc., a South Korean startup specializing in AI-driven protein therapeutics design, has published a study showcasing the capabilities of its AI platform, GaluxDesign, in de novo antibody design.

SARS-CoV-2, the virus responsible for COVID-19, infects cells by binding its spike protein to angiotensin-converting enzyme 2 (ACE2) receptors.